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Abstract: 
 
Connexin 43 (Cx43) accrual and removal from gap junctions is a complex progress regulated by 
specific phosphorylations, ubiquitinations and binding and release of regulatory proteins on the C-
terminal tail of Cx43.  In Thévenin & Margraf et al., 2017, our lab showed that specific phosphorylations 
on the C-terminal tail of Cx43 occur before and after the binding and release of the scaffold protein Zona 
Occludens-1 (ZO-1).  In Kells-Andrews & Margraf et al., 2018 we show that K63-poly-ubiquitination 
occurs on residues K264 and K303 of the Cx43 C-terminal tail.  This undergraduate thesis summarizes 
the immunofluorescence imaging and quantification I have contributed to each of these papers, and 
additional work which further supports the ubiquitination of K264 and K303 on the Cx43 gap junction 
protein tail. 
 
 
Introduction/Overview: 
Gap junctions are transmembrane protein complexes which form channels between adjacent cells 
and permit passage of ions and other small signaling molecules.  These channels are composed of two 
hemichannels, each of which form via oligomerization of six protein subunits called connexins (Cxs). 
Gap junction channels aggregate between cells to form gap junction plaques, with newer channels added 
to the periphery, and older channels tending to be present towards the center of the plaque.  Cxs are 
expressed in a wide variety of tissues where they play important roles in cell-to-cell communication.  
Cx43, in particular, is of interest in its role in skeletal development (Ton & Iovine, 2013) and in 
contraction of the heart (van Veen et al., 2001).   
The Falk lab has discovered that specific phosphorylation and ubiquitination events on the C-
terminal tail of Cx43 decrease gap junction intercellular communication, ultimately leading to gap 
junction internalization and degradation (Fong et al., 2014, Nimlamool et al., 2015, Thévenin & Margraf 
et al., 2017, Kells-Andrews & Margraf et al., 2018).  Phosphorylation is the addition of a phosphate group 
to a serine, threonine or tyrosine in a protein whereas ubiquitination is the addition of a small 8.5kDa 
ubiquitin protein to a lysine.  Ubiquitination can occur by the addition of a single ubiquitin molecule, 
termed mono-ubiquitination, or by the addition of a chain of ubiquitin molecules, termed poly-
ubiquitination.  Poly-ubiquitin chains are linked through internal lysines in the ubiquitin protein, with 
possible linkages including linkage through lysine 48 to form a K48 poly-ubiquitin chain, or linkage 
through lysine 63 to form a K63 poly-ubiquitin chain, and other lysines.  K48 poly-ubiquitination is 
generally a signal for proteasomal degradation of the tagged protein, while K63 poly-ubiquitination 
commonly targets proteins for lysosomal degradation (Komander & Rape, 2012). 
 Previous studies have identified phosphorylation (p) of Cx43 on serines (S) 255, 262, 279/282, 
and 368 in the Cx43 C-terminal tail as associated with decreased GJ intercellular communication 
(reviewed in Thévenin & Margraf et al., 2013).  Previous studies also have identified ubiquitination on 
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gap junctions (reviewed in Leithe & Rivedal, 2007) but the type/s of ubiquitination, nor when in the Cx 
‘live-cycle’ they are occurring and the amino acid had not previously been shown. 
Binding proteins can also play important roles in channel accrual and internalization.  Zona 
Occludens-1 (ZO-1) is a scaffold protein which has been shown to regulate and slow the rate of accrual of 
Cx43 hemichannels to the plaque (Rhett et al., 2011).  ZO-1 binds to the extreme C-terminal end of the 
Cx43 tail.  Additional proteins which have been shown to bind to Cx43 include the endocytic protein 
clathrin and its adaptor, AP-2 (Fong et al., 2014).  AP-2/clathrin bind to two ‘tyrosine-based sorting 
signals’ located in the Cx43 tail, (265YAYF268 and 286YKLV289).  Additionally, the Nedd4 ubiquitin-E3-
ligase binds in the region 
283
PPGY
286
 (Leykauf et al., 2006). 
Immunofluorescence staining and high-resolution fluorescence microscopy can reveal much 
information about the gap junction plaque.  The technique, for example can establish colocalization of 
Cx43 with ubiquitin or a binding protein, the spatial distribution of these interactions in the gap junction 
plaque or within endocytosed, annular gap junctions, and the size and number of gap junction plaques 
between cells.  These methods by themselves are not always sufficient to determine direct protein 
interactions, as colocalization does not guarantee the interaction of two proteins, but immunofluorescence 
can provide strong support for interactions which otherwise have been revealed by co-
immunoprecipitation analyses.  
In this paper, I show that mutation of specific phosphorylation sites in the Cx43 C-terminal tail 
domain changes the distribution of ZO-1 in the gap junction plaque, supporting a specific sequence of 
phosphorylations occurring in relation to transitioning functional into non-functional gap junction 
channels that then are internalized via the endocytic clathrin pathway.  I also show that Cx43 gap 
junctions colocalize with mono and poly-ubiquitination-specific antibodies, as well as an antibody 
specific for K63 poly-ubiquitination, but that it does not colocalize with an antibody specific for K48 
poly-ubiquitination.  Finally, I show that mutation of specific lysines in the Cx43 tail can decrease or 
increase the amount of K63 poly-ubiquitin that is added to Cx43 in the gap junction plaque. 
 
 
Methods: 
Cell Culture, Transfection and Immunofluorescence Staining methods: 
 HeLa cells (Cat. No. CCL-2, American Type Culture Collection [ATCC]) or primary porcine 
Pulmonary Artery Endothelial Cells (PAECs) were grown on poly-L-lysine coated coverslips at 37ºC, 5% 
CO2 and 100% humidity in low glucose DMEM.  Hela cells, which do not endogenously express Cx43, 
were transfected with Cx43 cDNA constructs using Lipofectamine2000 (cat. no. 11668027, Invitrogen).  
Transfected cells were grown overnight, then fixed in 3.7% formaldehyde at room temperature for 15 
minutes.  PAECs, which endogenously express Cx43, where not transfected, and were fixed in 3.7% 
formaldehyde at room temperature for 15 minutes once they had reached 90% confluency.  Cells were 
permeabilized in 0.2% Triton X-100 in Phosphate Buffered Saline (PBS) at room temperature for 15 
minutes, then blocked with 10% Fetal Bovine Serum (FBS) in PBS for 30 minutes at room temperature.  
Primary antibodies were then applied for sequential overnight incubations (in an order listed in the 
following descriptions) at 4ºC.  Secondary antibodies were applied simultaneously with 1 μg/ml 4′,6-
diamidino-2-phenylindole (DAPI) (Cat. No. D1306; Molecular Probes) for one hour at room temperature.  
Cells were subsequently mounted in Fluoromount-G (cat. no. 0100-01, Southern Biotechnology). 
 
ZO-1 Colocalization with Cx43 Phosphorylation mutants: 
Cx43 constructs with mutated phosphorylation sites were transfected into HeLa cells.  Cx43 
cDNA constructs were previously constructed by A. Thévenin in the Falk lab as described in Thévenin & 
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Margraf et al., 2017.  In each mutant, a single serine (S) residue was replaced with either an alanine (A, 
that cannot become phosphorylated, and to simulate the non-phosphorylated state of serine) or glutamic 
acid (E, that simulates the phosphorylated state of serine), generating mutants S255A/E, S279/282A/E, 
S365A/E, S368A/E and S373A/E.  Transfected cells were stained with rabbit polyclonal anti-Cx43 
antibodies (cat. no. 3512, Cell Signaling Technology) diluted 1:200 in 10% FBS/PBS then with mouse 
monoclonal anti-ZO-1 antibodies (cat. no. 339100, Invitrogen) diluted 1:200 in 10% FBS/PBS followed 
by staining with secondary antibodies Alexa Fluor488-conjugated goat anti-rabbit (cat. no. A11008; 
Molecular Probes/Invitrogen) and Alexa Fluor568-conjugated goat anti-mouse (cat. no. A11031, 
Molecular Probes) diluted 1:1000 in 10% FBS/PBS and DAPI at RT for 1 hour. 
Cells were imaged using the Department of Biological Sciences new Zeiss 880 confocal 
microscope equipped with a 63x Plan-Apochromat oil-immersion objective.  Cells were additionally 
imaged on a Zeiss 880 confocal microscope equipped with an AiryScan scan-head (providing super-
resolution of up to 140nm resolution in x-y), and a Nikon Eclipse TE 2000E inverted fluorescence 
microscope, equipped with 60x and 100x Plan-Apochromat oil-immersion objectives, respectively, and an 
auxiliary magnifier increasing the objective power by 1.5. 
 
Ubiquitin Colocalization with Endogenous Cx43 Gap Junction Plaques: 
 PAEC cells were stained with primary rabbit polyclonal anti-peptide Cx43 antibodies (Cat. No. 
3512, Cell Signaling) or mouse monoclonal anti-Cx43 antibodies (clone 4E6.2) (cat. no. MAB3067, 
Millipore) diluted 1:500 in 10% FBS/PBS then with either primary mouse monoclonal anti-monoUb and 
polyUb (FK2) (cat. no. PW8810; Enzo, Farmingdale, NY), polyUb (FK1) (cat. no. PW8805; Enzo), K63-
polyUb specific (clone HWA4C4) (cat. no. PW0600; Enzo), or primary monoclonal K48-polyUb specific 
(clone Apu2) (cat. no. 05-1307; Millipore) antibodies diluted 1:200 in 10% FBS/PBS at 4°C overnight.  
Cells were then incubated in secondary antibodies (goat anti-rabbit Alexa Fluor488, goat anti-mouse 
Alexa Fluor568, goat anti-rabbit Alexa Fluor568, and goat anti-mouse Alexa488; cat. no. A11008, 
A11031, A11011, and A11001, respectively; Molecular Probes/Invitrogen) diluted 1:500 in 10% 
FBS/PBS.   
 Cells again were imaged with the Zeiss 880 confocal microscope equipped with a 63x Plan-
Apochromat oil-immersion objective.  To quantify colocalization of ubiquitin-specific antibodies with 
Cx43 antibodies in endogenous Cx43 plaques, GJ plaques of entire lateral membranes were outlined using 
the freeform tool in the Fiji ImageJ distribution (Schindelin et al., 2012).  The background fluorescence 
intensity for each antibody was calculated by averaging the mean image intensity of full field of view for 
the first and last z-sections, which captured cells but no gap junctions.  Thresholds for fluorescence signal 
for each antibody were chosen to be proportional to the background fluorescence intensity for each 
antibody.  For each cell pair, the area where colocalization occurred was calculated using the 
Colocalization plugin packaged with the Fiji distribution, which selected areas where both the Cx43 and 
ubiquitination antibody fluorescence was above the thresholds set.  This area was divided by the area 
where the Cx43 fluorescence was above threshold to obtain the proportion colocalization by area.  This 
procedure was performed for each z-section, and sections were summed together to produce the 
proportion colocalization by area per plaque.  Finally, the proportion colocalization by area for each 
condition was normalized by setting the fluorescence in the K48-polyUb channel to zero.  127, 117, 92, 
and 79 cell pairs were quantified for the FK2, FK1, K63-polyUb and K48-polyUb conditions respectively. 
 
K63 poly-ubiquitination with GJs assembled from Ubiquitination Mutants: 
Cx43 constructs with sites of potential ubiquitination mutated were transfected into HeLa cells.  
Constructs were generated earlier by R. Kells-Andrews in the Falk lab as described in Kells-Andrews & 
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Margraf et al., 2018.  In each construct, one, two, three or six (all lysines present in the Cx43 C-terminal 
domain except 3 lysines present in an essential domain located juxtaposed to the last Cx43 
transmembrane domain) lysines (K) were replaced with arginines (R).  The single mutants which were 
constructed were K264R, K287R, and K303R.  The double mutants which were constructed were 
K264/303R, K264/287R and K287/303R.  The triple mutant which was constructed was K264/287/303R, 
and the six lysine mutant which was constructed was K258/264/287/303/345/346R.  Cells were stained 
with mouse monoclonal anti-Cx43 antibodies (cat. no. 138300, Invitrogen) diluted 1:200 in 10% 
FBS/PBS, then rabbit monoclonal anti-K63-polyUb specific antibodies (cat. no. 05-1308, clone Apu3, 
Millipore) diluted 1:200 in 10% FBS/PBS.  Secondary antibodies, goat anti-mouse Alexa488 (A11001 
Molecular Probes/Invitrogen) and goat anti-rabbit A568 (A11011 Molecular Probes/Invitrogen) diluted 
1:500 in 10% FBS/PBS were applied with DAPI. These cells were also imaged on the Zeiss 880 confocal 
microscope equipped with a 63x Plan-Apochromat oil-immersion objective.   
To quantify relative colocalization of K63-polyUb antibodies with Cx43 antibodies in endogenous 
Cx43 plaques, GJ plaques were outlined using the freeform tool in the Fiji ImageJ distribution.  The area 
and mean fluorescence intensity in the red (ubiquitination) and green (Cx43) channels were measured for 
each plaque.  For each cell pair, the ratio of red/green intensity was calculated by adding the ratio of mean 
red/green intensity for each plaque in the cell pair while normalizing by the area of each plaque within the 
cell pair.  22, 38, 24, 42, 43, 35, 31, 28, and 43 cell pairs were quantified for the wt, K264R, K287R, 
K303, K264/303R, K264/287R, K287/303R, 3K/R, and 6K/R conditions respectively. Experiments to 
reproduce these co-localization experiments are currently ongoing. 
 
 
Results: 
 
Specific Phosphorylation Mutants alter the distribution of ZO-1 in gap junction plaques: 
Mutating specific serines (phosphorylation sites) in the Cx43 C-terminal tail modified the 
distribution of ZO-1 in the gap junction plaque.  Figure 1 shows the distribution of ZO-1 in the gap 
junction plaque for wt Cx43 and ten phosphorylation-deficient or phosphorylation-mimetic mutants.  For 
wild-type Cx43, ZO-1 accumulates on the outer rim of the plaques, consistent with its role in accruing gap 
junction channels to the edge of plaques.  Analyses demonstrate that in some mutants (S255A/E, 
S279/282A/E), this wild-type rim stain is preserved, indicating that these phosphorylations occur 
downstream of ZO-1/Cx43 interaction, and thus do not affect ZO-1 binding or release.  In other mutants 
(S365A/E, S368A/E and S373A) the ZO-1 distribution was no longer restricted to the rim of the plaques, 
and instead was distributed throughout the plaques, suggesting that mutation of these phosphorylations 
disrupt ZO-1 release from Cx43, and thus these phosphorylations likely occur upstream of ZO-1 release, 
but downstream of ZO-1 binding.  One mutant, S373E, showed very little if any ZO-1 bound to the 
plaque.  This suggests that if S373 cannot become de-phosphorylated, that ZO-1 binding does not occur.  
Thus this phosphorylation and de-phosphorylation event occurs upstream of ZO-1 binding to Cx43. This 
effect was seen regardless of the microscope used to image the gap junction plaques.   
Figure 2 shows two selected mutants imaged with widefield (150x), confocal (63x) and AiryScan 
super-resolution (60x) microscopy.  In each case, the rim, throughout, or absent ZO-1 stain was clearly 
distinguishable.  Thus, each technique is capable of demonstrating this specific ZO-1 distribution. 
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Figure 1: Distribution of ZO-1 in Cx43 phosphorylation mutants.  Cx43 phosphorylation mutants 
were transfected into HeLa cells.  Cx43 is stained in green, and ZO-1 is stained in red.  In wild-type Cx43, 
and the S255A/E, S279/282A/E mutants, ZO-1 is distributed along the rim of the plaque.  Mutating 
S365A/E, S368A/E and S373A caused the ZO-1 distribution to be distributed throughout the plaque.  
Mutating S373E prevented ZO-1 from binding to the gap junction plaque.  Line scans support this rim, 
throughout, or absent ZO-1 distribution in each condition.  This figure also appears in Thévenin & 
Margraf et al., 2017. 
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Figure 2: Imaging of ZO-1 distribution in Cx43 plaques using different microscopic techniques.  
The ZO-1 distribution (red) in the Cx43 gap junction plaque (green) was imaged using widefield (150x), 
confocal (63x) and AiryScan super-resolution (63x) microscopy.  Scale bar is 5µm.  Images in the top row 
show the same size of field of view, and images within the bottom row show the same size of field of 
view.  The images which comprise this figure also appear in Thévenin & Margraf et al., 2017. 
 
Cx43 colocalizes with antibodies for K63 poly-ubiquitination: 
 To determine the main type of ubiquitination on the gap junction plaque, PAECs expressing 
endogenous Cx43 were stained with antibodies for FK2 (mono and poly-ubiquitin), FK1 (any type of 
poly-ubiquitin), K63 poly-ubiquitin specific and K48 poly-ubiquitin specific antibodies.  FK2, FK1 and 
K63 poly-ubiquitin antibodies colocalized with both the gap junction plaque and endocytosed annular gap 
junctions, while K48 poly-ubiquitin did not colocalize with gap junction plaques or annular gap junctions.  
Ubiquitin distribution was quantified by the percent area of the gap junction plaque per cell pair which 
contained a ubiquitin stain above threshold.  FK2 colocalized across approximately 16% of the area of the 
plaque, while FK1 and K63 poly-ubiquitin colocalized across approximately 8% of the area of the plaque.  
The increase in FK2 versus FK1 suggests that an additional mono-ubiquitination event, besides the K63-
poly Ub specific ubiquitination, occurs on Cx43 in gap junctions, or on a Cx43 binding protein.  The lack 
of significant difference between the area of the K63 and FK1 antibodies indicates that K63 poly-
ubiquitination is the dominant ubiquitination on the gap junction plaque. 
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Figure 3: Ubiquitin-specific antibodies colocalize with Cx43 in GJs and AGJs. Endogenously Cx43-
expressing primary porcine pulmonary artery endothelial cells (PAECs) were immunostained with 
antibodies directed against Cx43 (green) and ubiquitin specific antibodies (red). Below each panel, 
magnified insets highlight GJs and AGJs. Cx43 antibodies robustly colocalized with mono and polyUb 
specific antibodies (FK2) (A), only polyUb specific antibodies (FK1) (B), and with K63-polyUb specific 
antibodies (HWA4C4) at distinct areas of GJs and with AGJs (C), but not with K48-polyUb specific 
antibodies (Apu2) (D), suggesting that Cx43, or a Cx43-binding protein became K63-polyubiquitinated.  
The average proportion of area per cell pair where Cx43 and ubiquitin specific antibodies colocalized was 
quantified in (E).  Asterisks indicate significance level; ns: not significant, (*): p < .1, (**): p < .05, (***): 
p < .01.  This figure also appears in Kells-Andrews & Margraf et al., 2018.   
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Figure 4: Ubiquitination of Cx43 plaques in Ubiquitin Site Mutants.  (A) Representative images of 
the distribution of K63 poly-ubiquitination (red) in Cx43 gap junction plaques (green) are shown for 
ubiquitin site mutants. (B) Quantification of the ratio of mean fluorescence intensity in the red (K63 poly-
ubiquitin) to green (Cx43) channels per cell pair is shown. (C) A chart of the significance level between 
each value in (B) is shown. A modified version of this figure appears in Kells-Andrews & Margraf et al., 
2018. 
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Mutating K264R and K303R in the Cx43 C-terminal tail decreases K63 poly-ubiquitination 
 A panel of single, double, triple and six lysine Cx43 mutants (K264R, K287R, K303R, 
K264/303R, K264/287R, K287/303R, K264/287/303R, and K258/264/287/303/345/346R) were 
transfected into HeLa cells as presented in Figure 4.  The ratio of the Cx43 to K63 poly-ubiquitin mean 
fluorescence intensity for each cell pair was calculated.  This ratio significantly dropped for K264R, 
K303R and K264/303R, suggesting the K264 and K303 are the residues which are ubiquitinated in the 
Cx43 C-terminal tail.  However, when K287R was mutated, the ratio increased, suggesting that a 
mutation on K287R interrupts another downstream internalization event, stalling ubiquitinated Cx43 
channels at the plaque.  In the 3K/R and 6K/R mutants, the ratio of Cx43 to K63 poly-ubiquitin mean 
fluorescence was much more variable, and was significantly higher than wild-type Cx43.  In these 
mutants, it is possible an additional stress response occurs, and ubiquitination occurs either on another 
residue on Cx43, or on a Cx43 binding protein. 
 
Discussion and Future Directions: 
 
The ZO-1 distributions described in this paper, along with additional biochemical and functional 
analyses performed in the Falk lab, support a specific series of phosphorylation events with respect to the 
binding and release of ZO-1.  Our model, reproduced in Figure 5 from Thévenin & Margraf et al., 2017, 
claims that the phosphorylations in which mutants do not change the wild-type rim distribution of ZO-1 in 
the plaque (S255A/E, S279/282A/E), occur downstream of the ZO-1 release.  The mutants which change 
the ZO-1 distribution to be throughout the plaque (S365A/E, S368A/E, S373A) suggest that 
phosphorylation on S365 and S368 occur before ZO-1 release, but downstream of ZO-1 binding, as ZO-1 
binds but cannot disengage from the plaque.  The mutant which does not bind ZO-1, S373E suggests that 
a dephosphorylation on S373 is required for ZO-1 binding, and if this does not occur, then ZO-1 does not 
bind.  This model provides much insight into the importance and order of specific regulatory 
phosphorylations on the Cx43 C-terminal tail in relation to ZO-1 binding and release. 
 
 
Figure 5: ZO-1 binding and release in relation to Cx43 phosphorylation events.   
Reproduced from Thévenin & Margraf et al., 2017. 
 
 The ubiquitination colocalization imaging in endogenous Cx43 supports K63 poly-ubiquitination 
as the dominant poly-ubiquitination on the Cx43 gap junction plaque.  This seems reasonable, as K63 
poly-ubiquitination is a signal for endocytosis and lysosomal degradation, while K48 poly-ubiquitination 
is a signal for proteasomal degradation.  Cx43 is internalized as annular gap junction vesicles which are 
too large for initial proteasomal degradation, thus, targeting to the lysosome for degradation of the larger 
 12 
 
structure makes physiological sense.  This observation that K63 poly-ubiquitination occurs launched 
further studies on where the K63 poly-ubiquitination occurred on Cx43. 
The data on the ratio of K63 poly-ubiquitination to Cx43 fluorescence intensity is the newest work 
in this paper, and is not yet complete.  The data in Figure 4 present 15 images per condition over one 
staining experiment.  This experiment has been repeated, and I plan to image and analyze the second 
replicate to double my sample size.  This should hopefully enable me to make some claims about the 
average plaque area per cell pair for each of the mutants, which was very variable across cells, and needs 
a larger sample size to clarify.  Based on the trends in this sample, gap junction plaque area increased in 
size compared to wild-type for the 3K/R and 6K/R mutants, consistent with data in Kells-Andrews & 
Margraf et al., 2018.  However, single and double mutants tended to decrease in size, which is 
counterintuitive to our model, which predicts that mutating these sites should prevent ubiquitination, and 
thus slow gap junction turnover.  Additional replication could help to solidify or counter these trends.   
Furthermore, with additional data I may be able to make some claims about the variation seen in 
the mean Cx43 fluorescence intensity.  Increased Cx43 fluorescence intensity may be an indicator of 
tighter channel packing, a phenomenon that is not well understood with respect to Cx43 ubiquitination. 
For this experiment, the mean Cx43 (green) fluorescence intensity seems to vary across mutants.  While 
one could speculate about this variation now, there is also a chance that this variation is caused by an 
inconsistent amount of antibody stain applied to each slide.  Additional replication will reduce the 
likelihood of this variation being caused by experimental error, and allow us to speculate on why the 
Cx43 fluorescence intensity may be so different across ubiquitination site mutants.  
 As the ratio of K63 poly-ubiquitination to Cx43 fluorescence intensity is not significantly different 
between the K264R and K303R mutants, this suggests that blocking ubiquitination on one does not cause 
an accumulation of ubiquitination of the other ubiquitinated residue.  This suggests that the 
ubiquitinations on K264 and K303 may be simultaneous and not sequential, with both residues needing to 
become phosphorylated at the same time.  An exception to this rule may occur in the double mutants 
K264/287R and K287/303R, where the mutation on K287 may lead to stalling of gap junction proteins at 
the plaque, and thus a longer time interval for phosphorylation to occur, perhaps allowing a single 
phosphorylation of one of the residues to be possible.   
 To gain additional insight into the order of these phosphorylations, I could also analyze the 
percentage of plaque area that K63 poly-ubiquitin occupies in each of these mutants.  If the ubiquitination 
is simultaneous, we expect the K63 poly-ubiquitinated area to be the same for the K264R and K303R 
mutants, whereas if one ubiquitination occurs before the other, one of these mutants should have a much 
higher percent area of K63 poly-ubiquitination.   
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Figure 6: Preliminary quantification of K63-poly ubiquitination with Cx43 ubiquitin mutants. 
Preliminary quantification of data presented above are expected to improve once a larger sample size has 
been analyzed.  (A): Gap junction plaque area per cell pair.  (B): Mean Cx43 (green) fluorescence 
intensity per cell pair. 
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